CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation by Kubota T, Nakajima-Taniguchi C, Fukuda T, Funamoto M, Maeda M, Tange E, Ueki R, Kawashima K, Hara H, Fujio Y, Azuma J in The pharmacogenomics journal (2006).

[PMID: 16402086] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.